All Stories

  1. Ugonin L ameliorates pulmonary fibrosis as a novel TβRs inhibitor by regulating the TGF-β/TβRs signaling and autophagy
  2. Impact of prior COVID-19 vaccination on major adverse kidney events in patients with non-dialysis dependent chronic kidney disease: a global retrospective study
  3. Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient‐Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study
  4. Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study
  5. Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years
  6. Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?
  7. Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders
  8. Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases
  9. Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications
  10. The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
  11. Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis
  12. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study
  13. Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings
  14. Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients
  15. The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis
  16. Chronic pulmonary Aspergillosis in a patient with poorly controlled diabetes: A case report and literatures review
  17. Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases
  18. The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia
  19. The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis
  20. Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway
  21. Benefits of Cycling Wheelchair Training for Elderly with Physical Disability: A Prospective Cohort Study
  22. A Fatal Case of Chlorfenapyr Poisoning and the Therapeutic Implications of Serum Chlorfenapyr and Tralopyril Levels
  23. Structure Effect on the Response of ZnGa2O4 Gas Sensor for Nitric Oxide Applications
  24. The effect of inhaled corticosteroids on the outcomes of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
  25. Respiratory Muscle Training Can Improve Cognition, Lung Function, and Diaphragmatic Thickness Fraction in Male and Non-Obese Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study
  26. Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program
  27. Compared the Microbiota Profiles between Samples from Bronchoalveolar Lavage and Endotracheal Aspirates in Severe Pneumonia: A Real-World Experience
  28. Associations of Chinese Herbal Medicine Use with the Risks of Acute Exacerbation and Mortality in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
  29. Significance of the Modified NUTRIC Score for Predicting Clinical Outcomes in Patients with Severe Community-Acquired Pneumonia
  30. Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report
  31. GAP Score and CA-153 Associated with One-Year Mortality in Anti-MDA-5 Antibody-Positive Patients: A Real-World Experience
  32. Caloric Intake with High Ratio of Enteral Nutrition Associated with Lower Hospital Mortality for Patients with Acute Respiratory Distress Syndrome Using Prone Position Therapy
  33. Energy Achievement Rate Is an Independent Factor Associated with Intensive Care Unit Mortality in High-Nutritional-Risk Patients with Acute Respiratory Distress Syndrome Requiring Prolonged Prone Positioning Therapy
  34. Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study
  35. Prognostic Factors to Predict ICU Mortality in Patients with Severe ARDS Who Received Early and Prolonged Prone Positioning Therapy
  36. Prognostic Factors to Predict ICU Mortality in Patients with ARDS Who Received Early and Prolonged Prone Positioning Therapy
  37. The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment
  38. Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study
  39. Full versus Trophic Feeds in Critically Ill Adults with High and Low Nutritional Risk Scores: A Randomized Controlled Trial
  40. Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
  41. Prognostic score of prone positioning to predict outcome in paients with moderate to severe acute respiratory distress syndrome
  42. Comparison of Feeding Efficiency and Hospital Mortality between Small Bowel and Nasogastric Tube Feeding in Critically Ill Patients at High Nutritional Risk
  43. Prognostic Value of Cardiopulmonary Exercise Test, Pulmonary Function Test , and Questionnaires on Mortality in Patients With Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study
  44. Early Do-Not-Resuscitate Directives Decrease Invasive Procedures and Health Care Expenses During the Final Hospitalization of Life of COPD Patients
  45. Health Care Expenses for COPD with Late Do-Not-Resuscitate (DNR) Decisions Escalate Nearly 2-Fold in Final Admission of Life
  46. Pulmonary Embolism and Severe Asthma: Case Report and Literature Review
  47. Miliary Tuberculosis-Related Acute Respiratory Distress Syndrome Complicated with Hemophagocytic Lymphohistiocytosis Syndrome
  48. Adjuvant therapy with traditional Chinese medicine in a heart failure patient complicated by hospital-acquired pneumonia: A case report
  49. A 27‐year‐old female presented with diffuse alveolar haemorrhage due to breast angiosarcoma with lung metastasis
  50. Optimal Time and Target for Evaluating Energy Delivery after Adjuvant Feeding with Small Bowel Enteral Nutrition in Critically Ill Patients at High Nutrition Risk
  51. The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease
  52. Targeted Energy Intake Is the Important Determinant of Clinical Outcomes in Medical Critically Ill Patients with High Nutrition Risk
  53. Do-Not-Resuscitate (DNR) decisions in patients with terminal COPD
  54. Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications
  55. Evaluation of LPS-Induced Acute Lung Injury Attenuation in Rats by Aminothiazole-Paeonol Derivatives